J Klassen
Overview
Explore the profile of J Klassen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
75
Citations
421
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Rock G, Chin-Yee I, Cantin G, Giulivi A, Gluck S, Keating A, et al.
Transfus Med
. 2000 Apr;
10(1):67-75.
PMID: 10760205
The most common methods used for evaluation of the haematopoietic stem cell content of peripheral blood apheresis products are the colony forming cell assay and the enumeration of CD34+ cells...
12.
Stewart D, Guo D, Luider J, Auer I, Klassen J, Morris D, et al.
Bone Marrow Transplant
. 2000 Mar;
25(4):435-40.
PMID: 10723588
CD90 or Thy-1 is an antigen co-expressed with CD34+ on putative immature hematopoietic stem cells. Peak mobilization of CD34+90+ cells into the blood occurs a few days earlier than peak...
13.
Russell J, Larratt L, Brown C, Turner A, Chaudhry A, Booth K, et al.
Bone Marrow Transplant
. 2000 Jan;
24(11):1177-83.
PMID: 10642805
We have compared the outcomes of 87 patients with acute myelogenous leukemia (AML) and myelodysplasia (MDS) receiving matched sibling transplants with stem cells from peripheral blood (blood cell transplant, BCT)...
14.
Stewart D, Guo D, Luider J, Auer I, Klassen J, Ching E, et al.
Bone Marrow Transplant
. 1999 Jul;
23(12):1237-43.
PMID: 10414909
Data were analyzed on 178 consecutive patients (median age 43 years) who underwent autologous blood stem cell transplantation (ABSCT) at a single institution to determine if CD34+ subsets (CD34+38-, CD34+33-,...
15.
Sadler D, Gordon A, Klassen J, Saliken J, So C, Gray R
Bone Marrow Transplant
. 1999 Apr;
23(2):179-82.
PMID: 10197805
Apheresis is an increasingly important procedure in the treatment of a variety of conditions, sometimes performed via peripheral access because of concern over major complications associated with central venous catheter...
16.
Stewart D, Guo D, Morris D, Poon M, Ruether B, Jones A, et al.
Bone Marrow Transplant
. 1999 Apr;
23(2):111-7.
PMID: 10197794
The study purpose was to determine if G-CSF plus dose-intensive cyclophosphamide 5.25 g/m2, etoposide 1.05 g/m2 and cisplatin 105 mg/m2 (DICEP) results in superior autologous blood stem cell mobilization (BSCM)...
17.
Corbalan R, Acevedo M, Godoy I, Jalil J, Campusano C, Klassen J
J Card Fail
. 1998 Sep;
4(2):115-9.
PMID: 9730104
Background: Congestive heart failure (CHF) is characterized by increased activity of the renin-angiotensin system. Recent experimental studies have shown that infusion of angiotensin II results in depressed plasma levels of...
18.
Stewart D, Guo D, Sutherland J, Ruether B, Jones A, Poon M, et al.
Ann Oncol
. 1998 Mar;
8(12):1277-9.
PMID: 9496396
Background: Few data are available on the cost, safety, and long-term efficacy of single-agent high-dose melphalan (HDM) followed by autologous bone marrow (ABMT) or blood stem cell (ABSCT) transplantation in...
19.
Luider J, Brown C, Selinger S, Quinlan D, Karlsson L, Ruether D, et al.
J Hematother
. 1998 Mar;
6(6):575-80.
PMID: 9483192
Mobilization of hematopoietic progenitor cells by G-CSF was attempted on 89 occasions in 85 healthy donors. Three dose ranges of G-CSF were chosen for analysis: low (4-7.4 micrograms/kg), intermediate (7.5-10...
20.
Russell J, Desai S, Herbut B, Brown C, Luider J, Ruether J, et al.
Bone Marrow Transplant
. 1997 May;
19(9):861-6.
PMID: 9156258
Eleven patients with high-risk hematologic malignancy received cryopreserved but otherwise unmanipulated blood cell transplants (BCT) from partially mismatched family members in whom progenitor cells had been mobilized by G-CSF. Donors...